Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for Early‐State Detection of Cancer
Small · 2025
DOI: 10.1002/smll.202401787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Riya Mallik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India. Hauptthemen laut MEDLINE: Silicon Dioxide, Magnetic Resonance Imaging, Nanoparticles, Contrast Media. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Department of Biotechnology, Department of Science and Technology, Ministry of Science and Technology, India, Department of Biotechnology, Government of West Bengal.
Abstract (Originalsprache)
Cancer is recognized as one of the major causes of mortality, however, early‐stage detection can increase the survival chance greatly. It is recognized that folate receptors are gradually overexpressed in the cellular membrane with the progress of cancer from stage 1 to stage 4. Utilizing the fact, herein, developed a porous silica nanoparticle system C1 @SiO 2 –FA–NP; A) impregnated with thermodynamically stable Mn(II) complex ( 1 ) molecules within the core of the nanoparticle, and B) surface functionalized with folate units. It exhibited a high longitudinal relaxivity value r 1 = 21.45 m M −1 s −1 that substantially increased to r 1 = 40.97 m M −1 s −1 in the presence of 0.67 m M concentration of BSA under the physiological condition. The in vitro fluorescent images after surface conjugation of C1 @SiO 2 –FA–NP with FITC (fluorescein isothiocyanate) buttressed the inclusion of the nanoparticle exclusively within the cancerous HeLa cells than that of healthy HEK293 cells. The importance of the surface‐bound folate unit in the nanoparticle is further established by comparing the fluorescent images of HeLa cells in the absence of the group. Finally, the applicability of C1 @SiO 2 –FA–NP as the T 1 ‐weighted MRI contrast agent for early‐stage cancer diagnosis is established within C57BL/6 mice after infecting the mice with HeLa cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India.
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India.
- Department of NMR, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
- Department of Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
ORCID-Profile: Chandan Mukherjee
Förderung
- Department of Biotechnology
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Biotechnology, Government of West Bengal
Zitieren
APA
Mallik, R., Saha, M., Ghosh, B., Chauhan, N., Mohan, H., Kumaran, S. S., & Mukherjee, C. (2025). Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for Early‐State Detection of Cancer. Small. https://doi.org/10.1002/smll.202401787
Vancouver
Mallik R, Saha M, Ghosh B, Chauhan N, Mohan H, Kumaran SS, et al. Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for Early‐State Detection of Cancer. Small. 2025. doi:10.1002/smll.202401787
BibTeX
@article{Mallik2025,
author = {Mallik, Riya and Saha, Muktashree and Ghosh, Basab and Chauhan, Nisha and Mohan, Hari and Kumaran, S Senthil and Mukherjee, Chandan},
title = {Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for Early‐State Detection of Cancer},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202401787}
}
EUVIMED